Led by its robotic automation and genetic analysis products, Beckman Coulter’s biomedical research division contributed 5 percent growth toward the company’s total revenues of $581 million for the quarter ending Sept. 30.

Beckman’s overall sales grew 8.7 percent for the period, compared to the same quarter in 2003, boosted by 10-percent growth in sales of $420 million for its clinical diagnostics unit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.